Inovio Pharma (INO) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.24 +2.48%
EPS Growth %: +75.9%
Financial Fact:
Net loss: -20.76M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +75.9%
Financial Fact:
Net loss: -20.76M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $866.86 thousand versus the consensus estimate of $3.93 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Deutsche Bank Upgrades Wickes Group plc (WIX:LN) to Hold
- Barclays says AI trade is maturing, favors greater diversification
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
